Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Iloprost

A synthetic analogue of prostacyclin that widens blood vessels: inhaled, it is used for pulmonary arterial hypertension, an indication approved in the United States in 2004, and it is also used in circulatory disorders such as Raynaud's phenomenon. This family brings together the active ingredient, labelled standards and other impurities.

Did you know?In February 2024 it became the first medicine approved in the United States for severe frostbite, aimed at reducing the risk of amputating fingers and toes.

IloprostGo to the active ingredient →
IloprostActive ingredientIloprostCat. No. P-I025-001CAS 78919-13-8

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.